Viral loads and profile of the patients infected with SARS‐CoV‐2 Delta, Alpha, or R.1 variants in Tokyo
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
The rapid spread of the Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) became a serious concern worldwide in summer 2021. We examined the copy number and variant types of all SARS‐CoV‐2‐positive patients who visited our hospital from February to August 2021 using polymerase chain reaction (PCR) tests. Whole genome sequencing was performed for some samples. The R.1 variant (B.1.1.316) was responsible for most infections in March, replacing the previous variant (B.1.1.214); the Alpha (B.1.1.7) variant caused most infections in April and May; and the Delta variant (B.1.617.2) was the most prevalent in July and August. There was no significant difference in the copy numbers among the previous variant cases ( n = 29, median 3.0 × 10 4 copies/µl), R.1 variant cases ( n = 28, 2.1 × 10 5 copies/µl), Alpha variant cases ( n = 125, 4.1 × 10 5 copies/µl), and Delta variant cases ( n = 106, 2.4 × 10 5 copies/µl). Patients with Delta variant infection were significantly younger than those infected with R.1 and the previous variants, possibly because many elderly individuals in Tokyo were vaccinated between May and August. There was no significant difference in mortality among the four groups. Our results suggest that the increased infectivity of Delta variant may be caused by factors other than the higher viral loads. Clarifying these factors is important to control the spread of Delta variant infection.
Article activity feed
-
-
SciScore for 10.1101/2021.09.21.21263879: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: This study was approved by the Medical Research Ethics Committee of Tokyo Medical and Dental University (approval number: M2020-004) and was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Whole genome sequencing (WGS) was performed to identify the lineages of representative samples using a next-generation sequencer. WGSsuggested: NoneLibraries were prepared using the QIAseq SARS-CoV-2 Primer Panel Kit (QIAGEN) and sequenced using the MiSeq (Illumina, Inc.; San Diego, USA). MiSeqsu…SciScore for 10.1101/2021.09.21.21263879: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: This study was approved by the Medical Research Ethics Committee of Tokyo Medical and Dental University (approval number: M2020-004) and was conducted in accordance with the ethical standards of the 1964 Helsinki Declaration. Sex as a biological variable not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Whole genome sequencing (WGS) was performed to identify the lineages of representative samples using a next-generation sequencer. WGSsuggested: NoneLibraries were prepared using the QIAseq SARS-CoV-2 Primer Panel Kit (QIAGEN) and sequenced using the MiSeq (Illumina, Inc.; San Diego, USA). MiSeqsuggested: (A5-miseq, RRID:SCR_012148)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-